Outlier test for reference replicate crossover study design [Regulatives / Guidelines]

posted by ElMaestro  – Belgium?, 2019-08-13 15:28  – Posting: # 20495
Views: 161

Hi Abhimanyu,

» I have question regarding outlier test (Using Lund's method) for reference replicate crossover study design.

Sounds like a bad idea.

» How can we find outlier? which one will be appropriate scenario for any regulatory point of view?

The trick is to avoid generating outliers. In my small universe, there is no problem that merits a solution involving identification and and removal of outliers.

I could be wrong, but...
Best regards,
ElMaestro

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,687 posts in 4,178 threads, 1,352 registered users;
online 15 (0 registered, 15 guests [including 6 identified bots]).
Forum time (Europe/Vienna): 21:09 CEST

The fundamental cause of trouble in the world today is
that the stupid are cocksure
while the intelligent are full of doubt.    Bertrand Russell

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5